OBJECTIVES: Up- and down-regulation of inflammatory response was described in blood cells from septic patients, according to the stage of sepsis and the cells evaluated. This study aimed to evaluate the Toll-like receptor (TLR) signaling pathway gene expression in peripheral blood mononuclear cells (PBMC) and neutrophils in patients throughout the different stages of sepsis. DESIGN: Prospective, observational study. SETTINGS: Two emergency rooms and two intensive care units in one university and one teaching hospital. PATIENTS AND CONTROLS: A total of 15 septic patients, five with sepsis, five with severe sepsis, and five with septic shock, in addition to five healthy volunteers were enrolled. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: The Human-TLR Signaling Pathway, which comprises 84 genes related to TLR-mediated signal transduction, was evaluated by real time polymerase chain reaction in PBMC and neutrophils obtained from patients and controls. The fold change for each gene (2(-Delta DeltaCt)) was compared between the groups. Genes with fold changes greater than 2 and significant changes in DeltaCT are reported as differently expressed. The fold change ratios in PBMC gene expression between septic patients and healthy controls revealed a dynamic process according to the stage of sepsis, tending toward down-regulation of the TLR signaling pathway in PBMC in the more severe forms of the disease. However, the differential gene expression was restricted to five down-regulated genes in septic shock patients, which are found in the effector and downstream pathways. Neutrophils showed a different pattern of adaptation. Patients with sepsis, severe sepsis, and septic shock presented a broad gene up-regulation, which included all functional groups evaluated and persisted throughout the stages of the disease. CONCLUSIONS: TLR-signaling pathway genes are differently regulated in PBMC and neutrophils of septic patients, and are dynamically modulated throughout the different stages of sepsis.
OBJECTIVES: Up- and down-regulation of inflammatory response was described in blood cells from septic patients, according to the stage of sepsis and the cells evaluated. This study aimed to evaluate the Toll-like receptor (TLR) signaling pathway gene expression in peripheral blood mononuclear cells (PBMC) and neutrophils in patients throughout the different stages of sepsis. DESIGN: Prospective, observational study. SETTINGS: Two emergency rooms and two intensive care units in one university and one teaching hospital. PATIENTS AND CONTROLS: A total of 15 septic patients, five with sepsis, five with severe sepsis, and five with septic shock, in addition to five healthy volunteers were enrolled. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: The Human-TLR Signaling Pathway, which comprises 84 genes related to TLR-mediated signal transduction, was evaluated by real time polymerase chain reaction in PBMC and neutrophils obtained from patients and controls. The fold change for each gene (2(-Delta DeltaCt)) was compared between the groups. Genes with fold changes greater than 2 and significant changes in DeltaCT are reported as differently expressed. The fold change ratios in PBMC gene expression between septic patients and healthy controls revealed a dynamic process according to the stage of sepsis, tending toward down-regulation of the TLR signaling pathway in PBMC in the more severe forms of the disease. However, the differential gene expression was restricted to five down-regulated genes in septic shockpatients, which are found in the effector and downstream pathways. Neutrophils showed a different pattern of adaptation. Patients with sepsis, severe sepsis, and septic shock presented a broad gene up-regulation, which included all functional groups evaluated and persisted throughout the stages of the disease. CONCLUSIONS: TLR-signaling pathway genes are differently regulated in PBMC and neutrophils of septic patients, and are dynamically modulated throughout the different stages of sepsis.
Authors: Rachel Z Blumhagen; Brenna R Hedin; Kenneth C Malcolm; Ellen L Burnham; Marc Moss; Edward Abraham; Tristan J Huie; Jerry A Nick; Tasha E Fingerlin; Scott Alper Journal: Am J Physiol Lung Cell Mol Physiol Date: 2017-08-03 Impact factor: 5.464
Authors: Fabricia Petronilho; Francieli Vuolo; Letícia Selinger Galant; Larissa Constantino; Cristiane Damiani Tomasi; Vinicius Renne Giombelli; Cláudio Teodoro de Souza; Sabrina da Silva; Denise Frediani Barbeiro; Francisco Garcia Soriano; Emílio Luiz Streck; Cristiane Ritter; Alfeu Zanotto-Filho; Matheus Augusto Pasquali; Daniel Pens Gelain; José Luiz Rybarczyk-Filho; José Cláudio Fonseca Moreira; Norman L Block; Rafael Roesler; Gilberto Schwartsmann; Andrew V Schally; Felipe Dal-Pizzol Journal: Mol Med Date: 2012-10-24 Impact factor: 6.354
Authors: Joshua W Kuethe; Rachael Mintz-Cole; Bobby L Johnson; Emily F Midura; Charles C Caldwell; Barbara St Pierre Schneider Journal: Nurs Res Date: 2014 Nov-Dec Impact factor: 2.381
Authors: Farag Bleiblo; Paul Michael; Danielle Brabant; Chilakamarti V Ramana; Tc Tai; Mazen Saleh; Joseph E Parrillo; Anand Kumar; Aseem Kumar Journal: Int J Clin Exp Med Date: 2012-01-15
Authors: Andra L Blomkalns; Lynn L Stoll; Wassim Shaheen; Sara A Romig-Martin; Eric W Dickson; Neal L Weintraub; Gerene M Denning Journal: J Inflamm (Lond) Date: 2011-02-25 Impact factor: 4.981
Authors: Marcin F Osuchowski; Daniel G Remick; James A Lederer; Charles H Lang; Ansgar O Aasen; Mayuki Aibiki; Luciano C Azevedo; Soheyl Bahrami; Mihaly Boros; Robert Cooney; Salvatore Cuzzocrea; Yong Jiang; Wolfgang G Junger; Hiroyuki Hirasawa; Richard S Hotchkiss; Xiang-An Li; Peter Radermacher; Heinz Redl; Reinaldo Salomao; Amin Soebandrio; Christoph Thiemermann; Jean-Louis Vincent; Peter Ward; Yong-Ming Yao; Huang-Ping Yu; Basilia Zingarelli; Irshad H Chaudry Journal: Shock Date: 2014-06 Impact factor: 3.533